Cargando…
Cracking the combination: Gut hormones for the treatment of obesity and diabetes
Obesity and type 2 diabetes are a veritable global pandemic. There is an imperative to develop new therapies for these conditions that can be delivered at scale to patients, which deliver effective and titratable weight loss, amelioration of diabetes, prevention of diabetic complications and improve...
Autores principales: | Alexiadou, Kleopatra, Anyiam, Oluwaseun, Tan, Tricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563152/ https://www.ncbi.nlm.nih.gov/pubmed/30466162 http://dx.doi.org/10.1111/jne.12664 |
Ejemplares similares
-
Gastrointestinal Peptides as Therapeutic Targets to Mitigate Obesity and Metabolic Syndrome
por: Alexiadou, Kleopatra, et al.
Publicado: (2020) -
Management of Diabetic Foot Ulcers
por: Alexiadou, Kleopatra, et al.
Publicado: (2012) -
The Metabolomic Effects of Tripeptide Gut Hormone Infusion Compared to Roux-en-Y Gastric Bypass and Caloric Restriction
por: Jones, Ben, et al.
Publicado: (2021) -
Hormonal Gut–Brain Signaling for the Treatment of Obesity
por: Roh, Eun, et al.
Publicado: (2023) -
Bowels control brain: gut hormones and obesity
por: Bewick, Gavin A.
Publicado: (2012)